FXR-regulated COX6A2 triggers mitochondrial apoptosis of pancreatic β-cell in type 2 diabetes
2024

COX6A2's Role in Pancreatic β-Cell Death in Type 2 Diabetes

Sample size: 3 publication 10 minutes Evidence: high

Author Information

Author(s): Shao Lianqi, Kong Xiangchen, Lv Simian, Shu Xingsheng, Ma Xiaosong, Ai Xiaojiao, Yan Dan, Ying Ying

Primary Institution: Shenzhen University Medical School, Shenzhen, PR China

Hypothesis

The study investigates the role of FXR-regulated COX6A2 in diabetic β-cell apoptosis.

Conclusion

The study concludes that COX6A2 promotes β-cell apoptosis in type 2 diabetes through a mechanism involving VDAC1.

Supporting Evidence

  • COX6A2 expression was increased in islets from diabetic animals.
  • Overexpression of COX6A2 facilitated β-cell apoptosis.
  • Deficiency of COX6A2 attenuated β-cell apoptosis and improved diabetes symptoms.

Takeaway

In diabetes, a protein called COX6A2 makes insulin-producing cells in the pancreas die, which can make diabetes worse.

Methodology

The study used various animal models and cell lines to assess COX6A2 expression and its effects on β-cell apoptosis.

Limitations

The study did not measure RNA levels of Cox6a2 in islets from GK rats injected with AAV9-Cox6a2-KO.

Participant Demographics

Male Wistar and Goto-Kakizaki (GK) rats, and male C57BLKS/JGpt (BKS) mice.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41419-024-07302-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication